Audentes Therapeutics, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$157.9M

465 transactions

Summary

Audentes Therapeutics, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $11.6MSales: $60.7M36 insiders

Date	Insider	Type	Value
2020-01-15	Holles Natalie C.(President and COO)	U	$6.3M
2020-01-15	Conner Edward R.(SVP, Chief Medical Officer)	U	$1.5M
2020-01-15	Goldberg Mark Alan	U	$90K
2020-01-15	Conner Edward R.(SVP, Chief Medical Officer)	D	—
2020-01-15	Goldberg Mark Alan	D	—
2020-01-15	Goldberg Mark Alan	D	—
2020-01-15	Goldberg Mark Alan	D	—
2020-01-15	Goldberg Mark Alan	D	—
2020-01-15	Holles Natalie C.(President and COO)	D	—
2020-01-15	Holles Natalie C.(President and COO)	D	—
2020-01-15	Holles Natalie C.(President and COO)	D	—
2020-01-15	Holles Natalie C.(President and COO)	D	—
2020-01-15	Holles Natalie C.(President and COO)	D	—
2020-01-15	Holles Natalie C.(President and COO)	D	—
2020-01-15	Jarrett Jennifer	D	—
2020-01-15	Jarrett Jennifer	D	—
2020-01-15	Jarrett Jennifer	D	—
2020-01-15	Jarrett Jennifer	D	—
2020-01-15	LANGE LOUIS G	D	—
2020-01-15	LANGE LOUIS G	D	—

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Audentes Therapeutics, Inc. — Contributions, Lobbying & Contracts | Poliscope